Beyond Air, Inc. Increase (Decrease) in Other Accrued Liabilities
Beyond Air, Inc. (XAIR) reported Increase (Decrease) in Other Accrued Liabilities of $625.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherAccruedLiabilities · last filed 2026-08-13
- Beyond Air, Inc. increase (decrease) in other accrued liabilities for the quarter ending 2026-06-30 was $625.00K, a 9.55% decline year-over-year.
- Beyond Air, Inc. increase (decrease) in other accrued liabilities for the quarter ending 2026-03-31 was $770.00K.
- Beyond Air, Inc. increase (decrease) in other accrued liabilities for the quarter ending 2025-12-31 was $348.00K.
- Beyond Air, Inc. increase (decrease) in other accrued liabilities for the quarter ending 2025-09-30 was -$682.00K.
- Beyond Air, Inc. increase (decrease) in other accrued liabilities for fiscal 2026 was $1.13M.
- Beyond Air, Inc. increase (decrease) in other accrued liabilities for fiscal 2025 was -$6.36M.
- Beyond Air, Inc. increase (decrease) in other accrued liabilities for fiscal 2024 was -$12.71M, a 365.29% decline from fiscal 2023.
- Beyond Air, Inc. increase (decrease) in other accrued liabilities for fiscal 2023 was $4.79M, a 1.70% decline from fiscal 2022.
| Period end | Increase (Decrease) in Other Accrued Liabilities 3 month | Increase (Decrease) in Other Accrued Liabilities 6 month | Increase (Decrease) in Other Accrued Liabilities 9 month | Increase (Decrease) in Other Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $625.00K 10-Q · filed 2026-08-13 | $1.40M derived: sum of 2 quarters · filed 2026-08-13 | $1.74M derived: sum of 3 quarters · filed 2026-08-13 | $1.06M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $770.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-26 | $1.12M derived: sum of 2 quarters · filed 2026-06-26 | $436.00K derived: sum of 3 quarters · filed 2026-06-26 | $1.13M 10-K · filed 2026-06-26 |
| 2025-12-31 | $348.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-13 | -$334.00K derived: sum of 2 quarters · filed 2026-02-13 | $357.00K 10-Q · filed 2026-02-13 | -$189.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-09-30 | -$682.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-10 | $9.00K 10-Q · filed 2025-11-10 | -$537.00K derived: sum of 3 quarters · filed 2026-08-13 | -$2.42M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $691.00K 10-Q · filed 2026-08-13 | $145.00K derived: sum of 2 quarters · filed 2026-08-13 | -$1.74M derived: sum of 3 quarters · filed 2026-08-13 | -$4.82M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | -$546.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-26 | -$2.43M derived: sum of 2 quarters · filed 2026-06-26 | -$5.51M derived: sum of 3 quarters · filed 2026-06-26 | -$6.36M 10-K · filed 2026-06-26 |
| 2024-12-31 | -$1.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-13 | -$4.96M derived: sum of 2 quarters · filed 2026-02-13 | -$5.81M 10-Q · filed 2026-02-13 | -$5.29M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-09-30 | -$3.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-10 | -$3.93M 10-Q · filed 2025-11-10 | -$3.40M derived: sum of 3 quarters · filed 2025-11-10 | -$4.04M derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | -$848.00K 10-Q · filed 2025-08-12 | -$321.00K derived: sum of 2 quarters · filed 2025-08-12 | -$953.00K derived: sum of 3 quarters · filed 2025-08-12 | -$6.33M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $527.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-06-20 | -$105.00K derived: sum of 2 quarters · filed 2025-06-20 | -$5.48M derived: sum of 3 quarters · filed 2025-06-20 | -$12.71M 10-K · filed 2025-06-20 |
| 2023-12-31 | -$632.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-10 | -$6.01M derived: sum of 2 quarters · filed 2025-02-10 | -$13.24M 10-Q · filed 2025-02-10 | -$6.19M derived: sum of 4 quarters · filed 2025-02-10 |
| 2023-09-30 | -$5.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-12 | -$12.61M 10-Q · filed 2024-11-12 | -$5.56M derived: sum of 3 quarters · filed 2024-11-12 | -$4.71M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | -$7.23M 10-Q · filed 2024-08-06 | -$181.00K derived: sum of 2 quarters · filed 2024-08-06 | $671.00K derived: sum of 3 quarters · filed 2024-08-06 | -$2.31M derived: sum of 4 quarters · filed 2024-08-06 |
| 2023-03-31 | $7.05M derived: 10-K 12 month − 10-Q 9 month · filed 2024-06-24 | $7.90M derived: sum of 2 quarters · filed 2024-06-24 | $4.92M derived: sum of 3 quarters · filed 2024-06-24 | $4.79M 10-K · filed 2024-06-24 |
| 2022-12-31 | $852.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-02-12 | -$2.13M derived: sum of 2 quarters · filed 2024-02-12 | -$2.26M 10-Q · filed 2024-02-12 | |
| 2022-09-30 | -$2.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-11-13 | -$3.11M 10-Q · filed 2023-11-13 | ||
| 2022-06-30 | -$124.00K 10-Q · filed 2023-08-10 | |||
| 2022-03-31 | $4.87M 10-K · filed 2023-06-22 | |||
| 2021-06-30 | -$110.00K 10-Q · filed 2022-08-11 | |||
| 2021-03-31 | $707.00K 10-K · filed 2022-06-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |